{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:21:27Z","timestamp":1791397287199,"version":"4.3.3"},"reference-count":278,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T00:00:00Z","timestamp":1758412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004773","name":"Henan University","doi-asserted-by":"publisher","award":["CX3050A1000178"],"award-info":[{"award-number":["CX3050A1000178"]}],"id":[{"id":"10.13039\/501100004773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004773","name":"Henan University","doi-asserted-by":"publisher","award":["CX3050A1000179"],"award-info":[{"award-number":["CX3050A1000179"]}],"id":[{"id":"10.13039\/501100004773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psoriasis is a chronic inflammatory autoimmune skin disease characterized by erythematous plaques covered with silvery-white scales, often accompanied by systemic complications such as psoriatic arthritis and cardiovascular diseases. The disease and its systemic complications substantially impair quality of life, compromise socioeconomic status, and threaten patient safety. The occurrence and progression of this disease are related to the IL-23\/IL-17 axis and involve the aberrant activation and interactions of multiple immune cells, along with genetic predispositions and environmental triggers. Although current therapeutic approaches, including topical agents, systemic medications, biologic agents targeting key cytokines, and Janus Kinase inhibitors, can control symptoms and delay disease progression, a complete cure has not been achieved. Furthermore, these strategies face challenges relating to the cost, safety, efficacy and precision of targeting. This review summarizes recent advances in mechanistic research, highlighting the interplay among microorganisms, innate and adaptive immunity in psoriasis. We also evaluate a range of emerging therapies, including biologics, small-molecule inhibitors, Chimeric antigen receptor T-cell cell therapy, RNA interference-based strategies, and alternative medicine. Specifically, we focus on their novel mechanisms, efficacy challenges, safety profiles, and targeting accuracy. Finally, we assess their potential in personalized treatment, aiming to achieve long-term remission, and propose the future prospects of precision medicine in psoriasis management.<\/jats:p>","DOI":"10.3390\/ijms26189233","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T13:04:44Z","timestamp":1758546284000},"page":"9233","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Advances in Psoriasis Research: Decoding Immune Circuits and Developing Novel Therapies"],"prefix":"10.3390","volume":"26","author":[{"given":"Lanying","family":"Wang","sequence":"first","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine, Kaifeng 475004, China"},{"name":"School of Basic Medical Sciences, Henan University School of Medicine, Kaifeng 475004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Liu","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine, Kaifeng 475004, China"},{"name":"School of Basic Medical Sciences, Henan University School of Medicine, Kaifeng 475004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Tang","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine, Kaifeng 475004, China"},{"name":"School of Basic Medical Sciences, Henan University School of Medicine, Kaifeng 475004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfang","family":"Ma","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine, Kaifeng 475004, China"},{"name":"School of Basic Medical Sciences, Henan University School of Medicine, Kaifeng 475004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimei","family":"Wang","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine, Kaifeng 475004, China"},{"name":"School of Basic Medical Sciences, Henan University School of Medicine, Kaifeng 475004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9315-3716","authenticated-orcid":false,"given":"Qingguo","family":"Ruan","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine, Kaifeng 475004, China"},{"name":"School of Basic Medical Sciences, Henan University School of Medicine, Kaifeng 475004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-4794","authenticated-orcid":false,"given":"Shijun J.","family":"Zheng","sequence":"additional","affiliation":[{"name":"Joint National Laboratory for Antibody Drug Engineering, Henan University School of Medicine, Kaifeng 475004, China"},{"name":"School of Basic Medical Sciences, Henan University School of Medicine, Kaifeng 475004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic Arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.120237","article-title":"Metabolic syndrome in patients with psoriatic disease","volume":"89","author":"Gelfand","year":"2012","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jaad.2014.06.006","article-title":"Increased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis: Is psoriasis associated with atherosclerosis?","volume":"71","author":"Robati","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2340\/00015555-1273","article-title":"Living with psoriasis: Prevalence of shame, anger, worry, and problems in daily activities and social life","volume":"92","author":"Sampogna","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Nestle","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Mourits","year":"2009","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s41467-025-56719-8","article-title":"GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets","volume":"16","author":"Dand","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1365-2133.2000.03885.x","article-title":"HLA-C and guttate psoriasis","volume":"143","author":"Mallon","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis--results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(19)31773-8","article-title":"Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): Results from a phase 3, randomised controlled trial","volume":"394","author":"Reich","year":"2019","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/bjd.12230","article-title":"Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort","volume":"168","author":"Danielsen","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-4362.1996.tb03687.x","article-title":"Skin disease and socioeconomic conditions in rural Africa: Tanzania","volume":"35","author":"Gibbs","year":"1996","journal-title":"Int. J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103639","DOI":"10.1016\/j.autrev.2024.103639","article-title":"Global burden and cross-country inequalities in six major immune-mediated inflammatory diseases from 1990 to 2021: A systemic analysis of the Global Burden of Disease Study 2021","volume":"23","author":"Luo","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00403-024-02846-z","article-title":"Global burden and future trends in psoriasis epidemiology: Insights from the global burden of disease study 2019 and predictions to 2030","volume":"316","author":"Wang","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.immuni.2025.08.006","article-title":"Gut microbe-derived metabolites drive psoriatic inflammation via modulation of skin Th17 cells","volume":"58","author":"Wang","year":"2025","journal-title":"Immunity"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wu, J., Chen, H., Yang, R., Yu, H., Shang, S., and Hu, Y. (2022). Short-term exposure to ambient fine particulate matter and psoriasis: A time-series analysis in Beijing, China. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.1015197"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2421665","DOI":"10.1001\/jamanetworkopen.2024.21665","article-title":"Exposure to Air Pollution, Genetic Susceptibility, and Psoriasis Risk in the UK","volume":"7","author":"Wu","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamadermatol.2018.3631","article-title":"Association of Psoriasis with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"154","author":"Fu","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamadermatol.2022.1609","article-title":"Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults","volume":"158","author":"Ruan","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamacardio.2024.2859","article-title":"Exploring the Link Between Genetic Predictors of Cardiovascular Disease and Psoriasis","volume":"9","author":"Ramessur","year":"2024","journal-title":"JAMA Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/etm.2021.11102","article-title":"Metabolic comorbidities of psoriasis (Review)","volume":"23","author":"Branisteanu","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jdv.12165","article-title":"Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies","volume":"27","author":"Pouplard","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaad.2015.02.1127","article-title":"Genital psoriasis is associated with significant impairment in quality of life and sexual functioning","volume":"72","author":"Ryan","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2017.05.019","article-title":"Psoriasis and suicidality: A systematic review and meta-analysis","volume":"77","author":"Singh","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rompoti, N., Tsiori, S., Kontoangelos, K., Kouzoupis, A., Papageorgiou, C., Gregoriou, S., Stratigos, A., and Rigopoulos, D. (2024). Psychopathological Profile of Patients with Moderate-to-Severe Plaque Psoriasis and Its Correlation to DLQI: Results from a Prospective, Monocentric Clinical Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13216424"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0378-6323.45241","article-title":"A study of clinicohistopathological correlation in patients of psoriasis and psoriasiform dermatitis","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_36","first-page":"Cd011571","article-title":"Antistreptococcal interventions for guttate and chronic plaque psoriasis","volume":"3","author":"Dupire","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/archderm.1996.03890300147032","article-title":"How great is the risk of further psoriasis following a single episode of acute guttate psoriasis?","volume":"132","author":"Martin","year":"1996","journal-title":"Arch. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaad.2009.05.048","article-title":"Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation","volume":"62","author":"Rosenbach","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_39","first-page":"93","article-title":"Erythrodermic psoriasis: Pathophysiology and current treatment perspectives","volume":"6","author":"Singh","year":"2016","journal-title":"Psoriasis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2133.2010.09831.x","article-title":"Nail psoriasis in Germany: Epidemiology and burden of disease","volume":"163","author":"Augustin","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_41","first-page":"e79706","article-title":"Association of Psoriasis with Thyroid Disorders: A Tertiary Center-Based Cross-Sectional Study","volume":"17","author":"Alosaimi","year":"2025","journal-title":"Cureus"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/ijd.17848","article-title":"Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates","volume":"64","author":"Szepietowski","year":"2025","journal-title":"Int. J. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5021\/ad.2016.28.4.427","article-title":"Histopathological Differential Diagnosis of Psoriasis and Seborrheic Dermatitis of the Scalp","volume":"28","author":"Park","year":"2016","journal-title":"Ann. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"15382","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng.2827","article-title":"A large-scale screen for coding variants predisposing to psoriasis","volume":"46","author":"Tang","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ng.690","article-title":"Association analyses identify six new psoriasis susceptibility loci in the Chinese population","volume":"42","author":"Sun","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjd.12375","article-title":"Heritability of psoriasis in a large twin sample","volume":"169","author":"Skov","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Antonatos, C., Grafanaki, K., Asmenoudi, P., Xiropotamos, P., Nani, P., Georgakilas, G.K., Georgiou, S., and Vasilopoulos, Y. (2022). Contribution of the Environment, Epigenetic Mechanisms and Non-Coding RNAs in Psoriasis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10081934"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jid.2022.10.025","article-title":"Skin IL-17A and IFN-\u03b3 Production Correlate with Disease Severity in Patients with Psoriasis and Streptococcal Infection","volume":"143","author":"Mantengoli","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.4049\/jimmunol.2100686","article-title":"ERAP1 Controls the Autoimmune Response against Melanocytes in Psoriasis by Generating the Melanocyte Autoantigen and Regulating Its Amount for HLA-C*06:02 Presentation","volume":"207","author":"Arakawa","year":"2021","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jdermsci.2005.01.001","article-title":"HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis","volume":"38","author":"Shen","year":"2005","journal-title":"J. Dermatol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"589","DOI":"10.15252\/emmm.201607027","article-title":"RIG-I antiviral signaling drives interleukin-23 production and psoriasis-like skin disease","volume":"9","author":"Zhu","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jdermsci.2013.11.012","article-title":"Genetic polymorphism in the traf3ip2 gene is associated with psoriasis vulgaris in a Japanese population","volume":"73","author":"Hayashi","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of Psoriasis: A comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3892\/etm.2021.9999","article-title":"Infection-provoked psoriasis: Induced or aggravated (Review)","volume":"21","author":"Teng","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"adv34892","DOI":"10.2340\/actadv.v104.34892","article-title":"Significant Correlation Between Cutaneous Abundance of Streptococcus and Psoriasis Severity in Patients with FBXL19 Gene Variants","volume":"104","author":"Assarsson","year":"2024","journal-title":"Acta Derm. Venereol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2249.1999.01013.x","article-title":"Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis?","volume":"117","author":"Gudmundsdottir","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2249.2004.00600.x","article-title":"Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells","volume":"138","author":"Johnston","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2016-209815","article-title":"Incidence of autoimmune diseases in a nationwide HIV\/AIDS patient cohort in Taiwan, 2000\u20132012","volume":"76","author":"Yen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1473-3099(10)70101-8","article-title":"HIV-associated psoriasis: Pathogenesis, clinical features, and management","volume":"10","author":"Morar","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-106-1-165_2","article-title":"Psoriasis, gamma-interferon, and the acquired immunodeficiency syndrome","volume":"106","author":"Fuchs","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","article-title":"Triggers for the onset and recurrence of psoriasis: A review and update","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e15113","DOI":"10.1111\/dth.15113","article-title":"COVID-19 and exacerbation of dermatological diseases: A review of the available literature","volume":"34","author":"Aram","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/ije\/dyaa027","article-title":"Human papillomavirus infection associated with increased risk of new-onset psoriasis: A nationwide population-based cohort study","volume":"49","author":"Chen","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/ijd.14032","article-title":"Stress and psoriasis","volume":"57","author":"Rousset","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Wo\u017aniak, E., Owczarczyk-Saczonek, A., and Placek, W. (2021). Psychological Stress, Mast Cells, and Psoriasis-Is There Any Relationship?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413252"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2004.10.011","article-title":"Regulatory roles of sex hormones in cutaneous biology and immunology","volume":"38","author":"Kanda","year":"2005","journal-title":"J. Dermatol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Adachi, A., and Honda, T. (2022). Regulatory Roles of Estrogens in Psoriasis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11164890"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/1346-8138.12803","article-title":"Sex hormones in male psoriasis patients and their correlation with the Psoriasis Area and Severity Index","volume":"42","author":"Cemil","year":"2015","journal-title":"J. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/exd.14688","article-title":"Oestrogen inhibits psoriasis-like dermatitis induced by imiquimod in mice in relation to increased IL-10 producing cells despite elevated expression of IL-22, IL-23, IL-17 mRNA","volume":"32","author":"Kobayashi","year":"2023","journal-title":"Exp. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/138955712802762167","article-title":"Steroid hormones and sleep regulation","volume":"12","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2005.10.002","article-title":"Neuroimmunoendocrine circuitry of the \u2018brain-skin connection\u2019","volume":"27","author":"Paus","year":"2006","journal-title":"Trends Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bjd.21718","article-title":"Alcohol consumption and smoking in relation to psoriasis: A Mendelian randomization study","volume":"187","author":"Wei","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jdv.12164","article-title":"Alcohol consumption and psoriasis: A systematic literature review","volume":"27","author":"Brenaut","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1053.e1","DOI":"10.1016\/j.jaad.2014.06.016","article-title":"Diet in dermatology: Part II. Melanoma, chronic urticaria, and psoriasis","volume":"71","author":"Murzaku","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jaad.2018.11.015","article-title":"Smoking, but not alcohol, is associated with risk of psoriasis in a Taiwanese population-based cohort study","volume":"80","author":"Dai","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2016.06.021","article-title":"Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-\u03b2 Production by Epidermal Keratinocytes during Skin Injury","volume":"45","author":"Zhang","year":"2016","journal-title":"Immunity"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: From keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Albanesi, C., Madonna, S., Gisondi, P., and Girolomoni, G. (2018). The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01549"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1038\/ncomms8652","article-title":"NF-\u03baB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis","volume":"6","author":"Yan","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.jid.2023.02.026","article-title":"S100A9 Drives the Chronification of Psoriasiform Inflammation by Inducing IL-23\/Type 3 Immunity","volume":"143","author":"Veras","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","article-title":"Up-regulation of macrophage inflammatory protein-3 alpha\/CCL20 and CC chemokine receptor 6 in psoriasis","volume":"164","author":"Homey","year":"2000","journal-title":"J. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.1073\/pnas.1801377115","article-title":"I\u03baB\u03b6 is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes","volume":"115","author":"Hennig","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jid.2019.01.014","article-title":"IL-17 and IL-22 Promote Keratinocyte Stemness in the Germinative Compartment in Psoriasis","volume":"139","author":"Ekman","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.immuni.2020.06.004","article-title":"Excessive Polyamine Generation in Keratinocytes Promotes Self-RNA Sensing by Dendritic Cells in Psoriasis","volume":"53","author":"Lou","year":"2020","journal-title":"Immunity"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jaci.2021.02.041","article-title":"Immunomodulatory aged neutrophils are augmented in blood and skin of psoriasis patients","volume":"148","author":"Langereis","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/exd.13746","article-title":"Development of psoriasis by continuous neutrophil infiltration into the epidermis","volume":"27","author":"Katayama","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/s41590-023-01656-1","article-title":"E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8\/S100A9 release from neutrophils via transient gasdermin D pore formation","volume":"24","author":"Pruenster","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jid.2019.01.021","article-title":"IL-17E (IL-25) Enhances Innate Immune Responses during Skin Inflammation","volume":"139","author":"Senra","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-019-13756-4","article-title":"Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis","volume":"11","author":"Herster","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Shao, S., Fang, H., Dang, E., Xue, K., Zhang, J., Li, B., Qiao, H., Cao, T., Zhuang, Y., and Shen, S. (2019). Neutrophil Extracellular Traps Promote Inflammatory Responses in Psoriasis via Activating Epidermal TLR4\/IL-36R Crosstalk. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00746"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","article-title":"Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Hu, S.C., Yu, H.S., Yen, F.L., Lin, C.L., Chen, G.S., and Lan, C.C. (2016). Neutrophil extracellular trap formation is increased in psoriasis and induces human \u03b2-defensin-2 production in epidermal keratinocytes. Sci. Rep., 6.","DOI":"10.1038\/srep31119"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1096\/fj.201802090RR","article-title":"Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes","volume":"33","author":"Shao","year":"2019","journal-title":"FASEB J."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Liu, X.T., Shi, Z.R., Lu, S.Y., Hong, D., Qiu, X.N., Tan, G.Z., Xiong, H., Guo, Q., and Wang, L. (2022). Enhanced Migratory Ability of Neutrophils Toward Epidermis Contributes to the Development of Psoriasis via Crosstalk with Keratinocytes by Releasing IL-17A. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.817040"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jid.2020.07.028","article-title":"Neutrophils Enhance Cutaneous Vascular Dilation and Permeability to Aggravate Psoriasis by Releasing Matrix Metallopeptidase 9","volume":"141","author":"Chen","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1039\/D2BM01521H","article-title":"Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via the Ly6 antigen for psoriasiform dermatitis alleviation","volume":"11","author":"Lin","year":"2023","journal-title":"Biomater. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.4049\/jimmunol.1500551","article-title":"Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis","volume":"195","author":"Terhorst","year":"2015","journal-title":"J. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.celrep.2018.09.006","article-title":"Transcriptional Programming of Normal and Inflamed Human Epidermis at Single-Cell Resolution","volume":"25","author":"Cheng","year":"2018","journal-title":"Cell Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"Zaba","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaci.2012.02.020","article-title":"Mechanisms of IFN-\u03b3-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis","volume":"129","author":"Rebane","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/s41423-022-00940-8","article-title":"The epidermal immune microenvironment plays a dominant role in psoriasis development, as revealed by mass cytometry","volume":"19","author":"Zhou","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaci.2019.12.011","article-title":"BMP7 aberrantly induced in the psoriatic epidermis instructs inflammation-associated Langerhans cells","volume":"145","author":"Borek","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/jid.2014.98","article-title":"IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing \u03b3\u03b4 T cells","volume":"134","author":"Yoshiki","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"eaao1685","DOI":"10.1126\/scisignal.aao1685","article-title":"p38\u03b1 signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation","volume":"11","author":"Zheng","year":"2018","journal-title":"Sci. Signal."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jid.2016.11.033","article-title":"Dynamic Changes in Resident and Infiltrating Epidermal Dendritic Cells in Active and Resolved Psoriasis","volume":"137","author":"Martini","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2011.05.016","article-title":"Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets","volume":"128","author":"Fujita","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Wang, Y., Edelmayer, R., Wetter, J., Salte, K., Gauvin, D., Leys, L., Paulsboe, S., Su, Z., Weinberg, I., and Namovic, M. (2019). Monocytes\/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-41655-7"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1172\/JCI27180","article-title":"Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI27179","article-title":"Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation","volume":"116","author":"Stratis","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The Immunology of Psoriasis-Current Concepts in Pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-021-00622-y","article-title":"Understanding human mast cells: Lesson from therapies for allergic and non-allergic diseases","volume":"22","author":"Kolkhir","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-immunol-071719-094903","article-title":"Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns","volume":"38","author":"Galli","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s10787-023-01137-9","article-title":"Suprabasin-derived polypeptides: SBSN(50-63) induces inflammatory response via TLR4-mediated mast cell activation","volume":"31","author":"Zhou","year":"2023","journal-title":"Inflammopharmacology"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Ji, Y.Z., and Liu, S.R. (2019). Koebner phenomenon leading to the formation of new psoriatic lesions: Evidences and mechanisms. Biosci. Rep., 39.","DOI":"10.1042\/BSR20193266"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41577-020-00452-4","article-title":"\u03b3\u03b4 T cells in tissue physiology and surveillance","volume":"21","author":"Ribot","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A Critical Role of the IL-1\u03b2-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.1100804","article-title":"Identification of a novel proinflammatory human skin-homing V\u03b39V\u03b42 T cell subset with a potential role in psoriasis","volume":"187","author":"Laggner","year":"2011","journal-title":"J. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e005769","DOI":"10.1136\/jitc-2022-005769","article-title":"Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-\u03b3 to modulate antitumor T-cell response after cryo-thermal therapy","volume":"10","author":"Peng","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e169251","DOI":"10.1172\/JCI169251","article-title":"NKT cells promote Th1 immune bias to dengue virus that governs long-term protective antibody dynamics","volume":"134","author":"Choi","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41467-018-07911-6","article-title":"ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in Spondyloarthritis patients","volume":"10","author":"Venken","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Hu, Y., Chen, Y., Chen, Z., Zhang, X., Guo, C., Yu, Z., Xu, P., Sun, L., Zhou, X., and Gong, Y. (2021). Dysregulated Peripheral Invariant Natural Killer T Cells in Plaque Psoriasis Patients. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.799560"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Liu, P., Peng, C., Chen, X., Wu, L., Yin, M., Li, J., Qin, Q., Kuang, Y., and Zhu, W. (2021). Acitretin Promotes the Differentiation of Myeloid-Derived Suppressor Cells in the Treatment of Psoriasis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.625130"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00011-024-01918-0","article-title":"Shifting phenotype and differentiation of CD11b(+)Gr.1(+) immature heterogeneous myeloid derived adjuster cells support inflammation and induce regulators of IL17A in imiquimod induced psoriasis","volume":"73","author":"Sarkar","year":"2024","journal-title":"Inflamm. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","article-title":"IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages","volume":"160","author":"Jovanovic","year":"1998","journal-title":"J. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4049\/jimmunol.162.1.494","article-title":"IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: Synergistic or antagonist effects with IFN-gamma and TNF-alpha","volume":"162","author":"Albanesi","year":"1999","journal-title":"J. Immunol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2004.03.047","article-title":"Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathway","volume":"114","author":"Kawaguchi","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","article-title":"Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation","volume":"190","author":"Johnston","year":"2013","journal-title":"J. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1038\/ncomms4753","article-title":"IL-21 induces IL-22 production in CD4+ T cells","volume":"5","author":"Yeste","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/SHK.0000000000000900","article-title":"Interleukin-22 Prevents Microbial Dysbiosis and Promotes Intestinal Barrier Regeneration Following Acute Injury","volume":"48","author":"Hammer","year":"2017","journal-title":"Shock"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Bunte, K., and Beikler, T. (2019). Th17 Cells and the IL-23\/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143394"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Chang, H.W., Yan, D., Singh, R., Liu, J., Lu, X., Ucmak, D., Lee, K., Afifi, L., Fadrosh, D., and Leech, J. (2018). Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization. Microbiome, 6.","DOI":"10.1186\/s40168-018-0533-1"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"219ra8","DOI":"10.1126\/scitranslmed.3007828","article-title":"Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity","volume":"6","author":"Schlapbach","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Singh, T.P., Sch\u00f6n, M.P., Wallbrecht, K., Gruber-Wackernagel, A., Wang, X.J., and Wolf, P. (2013). Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0051752"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/jdv.13027","article-title":"Increased circulating follicular helper T cells and activated B cells correlate with disease severity in patients with psoriasis","volume":"29","author":"Niu","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1523-1747.1999.00749.x","article-title":"The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients","volume":"113","author":"Austin","year":"1999","journal-title":"J. Investig. Dermatol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1073\/pnas.1416922112","article-title":"IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells","volume":"112","author":"Guenova","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1038\/s41467-024-49577-3","article-title":"Sensory ASIC3 channel exacerbates psoriatic inflammation via a neurogenic pathway in female mice","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/path.1954","article-title":"Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions","volume":"209","author":"Baker","year":"2006","journal-title":"J. Pathol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.it.2006.10.001","article-title":"Peptidoglycan: A major aetiological factor for psoriasis?","volume":"27","author":"Baker","year":"2006","journal-title":"Trends Immunol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.4049\/jimmunol.155.8.4078","article-title":"Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris","volume":"155","author":"Menssen","year":"1995","journal-title":"J. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1046\/j.0022-202x.2001.01548.x","article-title":"Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions","volume":"117","author":"Lin","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Ror\u03b3t+ innate lymphocytes and \u03b3\u03b4 T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"ski2.64","DOI":"10.1002\/ski2.64","article-title":"CD8\u03b1\u03b1(+)T cells exert a pro-inflammatory role in patients with psoriasis","volume":"1","author":"Zhang","year":"2021","journal-title":"Ski. Health Dis."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Diani, M., Casciano, F., Marongiu, L., Longhi, M., Altomare, A., Pigatto, P.D., Secchiero, P., Gambari, R., Banfi, G., and Manfredi, A.A. (2019). Increased frequency of activated CD8(+) T cell effectors in patients with psoriatic arthritis. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-47310-5"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaci.2015.10.046","article-title":"Targeting CD8(+) T cells prevents psoriasis development","volume":"138","author":"Villanova","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J. Immunol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2023.11.017","article-title":"Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: Appearances can be deceptive","volume":"153","author":"Migayron","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/imm.13843","article-title":"The role and therapeutic strategies for tissue-resident memory T cells, central memory T cells, and effector memory T cells in psoriasis","volume":"173","author":"Deng","year":"2024","journal-title":"Immunology"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing \u03b1\u03b2 T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Lee, B.H., Bang, Y.J., Lim, S.H., Kang, S.J., Kim, S.H., Kim-Schulze, S., Park, C.G., Kim, H.J., and Kim, T.G. (2024). High-dimensional profiling of regulatory T cells in psoriasis reveals an impaired skin-trafficking property. EBioMedicine, 100.","DOI":"10.1016\/j.ebiom.2024.104985"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: Mechanism underlying unrestrained pathogenic effector T cell proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdermsci.2015.11.007","article-title":"Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3","volume":"81","author":"Yang","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.immuni.2023.06.021","article-title":"Obesity-induced dysregulation of skin-resident PPAR\u03b3(+) Treg cells promotes IL-17A-mediated psoriatic inflammation","volume":"56","author":"Sivasami","year":"2023","journal-title":"Immunity"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Lu, J., Ding, Y., Yi, X., and Zheng, J. (2016). CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity. Braz. J. Med. Biol. Res., 49.","DOI":"10.1590\/1414-431x20165374"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.0022-202X.2004.22709.x","article-title":"Identification of autoantigens in psoriatic plaques using expression cloning","volume":"123","author":"Jones","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_170","first-page":"1103","article-title":"Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity","volume":"16","author":"Guarneri","year":"2018","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Yunusbaeva, M., Valiev, R., Bilalov, F., Sultanova, Z., Sharipova, L., and Yunusbayev, B. (2018). Psoriasis patients demonstrate HLA-Cw*06:02 allele dosage-dependent T cell proliferation when treated with hair follicle-derived keratin 17 protein. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-24491-z"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/art.40830","article-title":"Identification of Novel Autoantibodies Associated With Psoriatic Arthritis","volume":"71","author":"Yuan","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Wang, S.Y., An, W.H., Wang, Z.S., Wang, W.L., Zhang, B., Xu, K.L., Guo, S.L., Gao, M., Li, B., and Huang, L. (2024). Incidentally cured psoriasis in a patient with refractory\/relapsed diffuse large B-cell lymphoma receiving CD19 CAR-T cell therapy: A case report. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1418768"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Mizumaki, K., Horii, M., Kano, M., Komuro, A., and Matsushita, T. (2021). Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-81588-8"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/rheumatology\/kez204","article-title":"Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis","volume":"58","author":"Mavropoulos","year":"2019","journal-title":"Rheumatology"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2017.04.010","article-title":"IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFN\u03b3-producing T cells","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions","volume":"65","author":"Menter","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1610-0387.2012.07919.x","article-title":"S3\u2014Guidelines on the treatment of psoriasis vulgaris (English version). Update","volume":"10","author":"Nast","year":"2012","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2015.05.010","article-title":"GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation","volume":"61","author":"Jones","year":"2015","journal-title":"J. Autoimmun."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1203475416655705","article-title":"2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009","volume":"20","author":"Papp","year":"2016","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0149-2918(98)80091-X","article-title":"Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: A multicenter study","volume":"20","author":"Koo","year":"1998","journal-title":"Clin. Ther."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaad.2013.06.027","article-title":"Topical treatments for chronic plaque psoriasis: An abridged Cochrane systematic review","volume":"69","author":"Mason","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/09546630600999219","article-title":"Calcipotriol cream: A review of its use in the management of psoriasis","volume":"17","author":"Segaert","year":"2006","journal-title":"J. Dermatol. Treat."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2103629","article-title":"Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis","volume":"385","author":"Lebwohl","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/00015550510039817","article-title":"0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study","volume":"86","author":"Ortonne","year":"2006","journal-title":"Acta Derm. Venereol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2133.1999.02927.x","article-title":"Tacrolimus ointment improves psoriasis in a microplaque assay","volume":"141","author":"Remitz","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00015550252948194","article-title":"A new calcipotriol\/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris","volume":"82","author":"Douglas","year":"2002","journal-title":"Acta Derm. Venereol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2009.08.026","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy","volume":"62","author":"Menter","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2133.1999.02977.x","article-title":"Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: A 1-year multicentre, randomized study. The PISCES Study Group","volume":"141","author":"Ho","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2007-06-096438","article-title":"Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3\/Stat-5 independent signaling pathway","volume":"111","author":"Elias","year":"2008","journal-title":"Blood"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0190-9622(88)70086-9","article-title":"Acitretin improves psoriasis in a dose-dependent fashion","volume":"18","author":"Goldfarb","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1600-0625.2008.00747.x","article-title":"UV-induced DNA damage initiates release of MMP-1 in human skin","volume":"17","author":"Dong","year":"2008","journal-title":"Exp. Dermatol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2310\/7750.2012.11124","article-title":"Phototherapy in psoriasis: A review of mechanisms of action","volume":"17","author":"Wong","year":"2013","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archderm.139.2.155","article-title":"Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: Differential regulation of cytokines at the single-cell level","volume":"139","author":"Walters","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2165\/00128071-200304070-00006","article-title":"The efficacy of calcipotriol + acitretin combination therapy for psoriasis: Comparison with acitretin monotherapy","volume":"4","author":"Rim","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1365-2133.2008.08564.x","article-title":"Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: A 24-week, randomized, controlled, investigator-blinded pilot trial","volume":"158","author":"Gisondi","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1021\/jm00016a018","article-title":"Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells","volume":"38","author":"Boehm","year":"1995","journal-title":"J. Med. Chem."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"106045","DOI":"10.1016\/j.intimp.2019.106045","article-title":"Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating I\u03baB\u03b6","volume":"79","author":"Tu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0190-9622(99)70359-2","article-title":"Acitretin in psoriasis: An overview of adverse effects","volume":"41","author":"Katz","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s40257-013-0054-4","article-title":"Treatment of psoriasis: Focus on clinic-based management with infliximab","volume":"15","year":"2014","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1067\/mjd.2001.112400","article-title":"Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort study","volume":"44","author":"Ho","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/371355a0","article-title":"Calcium signalling in T cells stimulated by a cyclophilin B-binding protein","volume":"371","author":"Bram","year":"1994","journal-title":"Nature"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Huang, H., Jin, K., Ouyang, K., Jiang, Z., Yang, Z., Hu, N., Dai, Y., Zhang, Y., Zhang, Q., and Han, Y. (2022). Cyclophilin A causes severe fever with thrombocytopenia syndrome virus-induced cytokine storm by regulating mitogen-activated protein kinase pathway. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.1046176"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/2013.jamadermatol.238","article-title":"Comparison of Ustekinumab with Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis: A Bayesian Network Meta-analysis","volume":"148","author":"Lin","year":"2012","journal-title":"Arch. Dermatol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0140-6736(24)01750-1","article-title":"IL-23 inhibition for chronic inflammatory disease","volume":"404","author":"Jairath","year":"2024","journal-title":"Lancet"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/annrheumdis-2020-219014","article-title":"Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: Results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study","volume":"80","author":"Mease","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjd.19262","article-title":"Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from the randomized placebo-controlled TRANSFIGURE study","volume":"184","author":"Reich","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa2102388","article-title":"Bimekizumab versus Adalimumab in Plaque Psoriasis","volume":"385","author":"Warren","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa2102383","article-title":"Bimekizumab versus Secukinumab in Plaque Psoriasis","volume":"385","author":"Reich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(23)01378-8","article-title":"Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): An international, multicentre, randomised, placebo-controlled trial","volume":"402","author":"Morita","year":"2023","journal-title":"Lancet"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"103293","DOI":"10.1016\/j.jaut.2024.103293","article-title":"The binding of extracellular cyclophilin A to ACE2 and CD147 triggers psoriasis-like inflammation","volume":"148","author":"Yang","year":"2024","journal-title":"J. Autoimmun."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4049\/jimmunol.1800189","article-title":"miR-340 Alleviates Psoriasis in Mice through Direct Targeting of IL-17A","volume":"201","author":"Bian","year":"2018","journal-title":"J. Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"112033","DOI":"10.1016\/j.intimp.2024.112033","article-title":"Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3\/IL-23 axis","volume":"133","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: Considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.05.017","article-title":"Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment","volume":"246","author":"Boakye","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Zhang, A., Zhang, G., Yang, H., Gong, B., Li, S., Wei, N., Xue, H., Wei, H., Wang, J., and Qiu, S. (2025). Treatment of pro-B acute lymphoblastic leukemia and severe plaque psoriasis with anti-CD19 CAR T cells: A case report. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1529745"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1016\/j.cell.2024.06.027","article-title":"Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"eadg6007","DOI":"10.1126\/sciadv.adg6007","article-title":"Adoptive T(reg) therapy with metabolic intervention via perforated microneedles ameliorates psoriasis syndrome","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"e13589","DOI":"10.1097\/MD.0000000000013589","article-title":"Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation: A case report","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2012.08.021","article-title":"Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation","volume":"68","author":"Kaffenberger","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.12998\/wjcc.v9.i23.6798","article-title":"Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report","volume":"9","author":"Ahn","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-022-01059-y","article-title":"Human umbilical cord mesenchymal stem cells for psoriasis: A phase 1\/2a, single-arm study","volume":"7","author":"Cheng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.21037\/atm-21-5028","article-title":"Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: Results of a single-arm pilot trial","volume":"9","author":"Yao","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00403-024-03296-3","article-title":"Distinct adaptive immune receptor feature of adipose-derived mesenchymal stem cells (AD-MSCs) treatment of psoriasis","volume":"316","author":"Tang","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_230","first-page":"8309103","article-title":"Mesenchymal Stem Cell Conditioned Media Ameliorate Psoriasis Vulgaris: A Case Study","volume":"2019","author":"Seetharaman","year":"2019","journal-title":"Case Rep. Dermatol. Med."},{"key":"ref_231","first-page":"119","article-title":"Extracellular Vesicles from miR-146a Overexpressing Mesenchymal Stem Cells Attenuate Imiquimod-Induced Psoriasis by Regulating Cytokine Expression","volume":"22","author":"Shao","year":"2025","journal-title":"Iran. J. Immunol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"122915","DOI":"10.1016\/j.lfs.2024.122915","article-title":"The safety and efficacy of adipose tissue-derived exosomes in treating mild to moderate plaque psoriasis: A clinical study","volume":"353","author":"Nilforoushzadeh","year":"2024","journal-title":"Life Sci."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.actbio.2025.04.015","article-title":"Drug-loaded microneedle patches containing regulatory T cell-derived exosomes for psoriasis treatment","volume":"198","author":"Ou","year":"2025","journal-title":"Acta Biomater."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jcyt.2025.01.007","article-title":"A phase 1, open-label study to determine safety and tolerability of the topical application of mesenchymal stem\/stromal cell (MSC) exosome ointment to treat psoriasis in healthy volunteers","volume":"27","author":"Chandran","year":"2025","journal-title":"Cytotherapy"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41591-024-02964-1","article-title":"Bispecific T cell engager therapy for refractory rheumatoid arthritis","volume":"30","author":"Bucci","year":"2024","journal-title":"Nat. Med."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Gao, C., Cai, Y., Wu, X., Song, J., Zheng, Q., Wang, M., Luo, Y., Luo, Y., Fei, X., and Zhang, Y. (2025). CRISPR\/Cas9-Mediated Knockout and Overexpression Studies Unveil the Role of PD-L1 in Immune Modulation in a Psoriasis-like Mouse Model. Inflammation.","DOI":"10.1007\/s10753-025-02281-w"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"eadl4336","DOI":"10.1126\/sciadv.adl4336","article-title":"Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders","volume":"10","author":"Tan","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Xiang, Y., Jiang, Y., Wang, Z., Wang, X., Ma, L., Ding, Y., Rui, B., Zhao, C., Li, X., and Xu, M. (2025). Targeting KAT8 alleviates self-RNA-driven skin inflammation by modulating histone H4 lysine 16 acetylation in psoriasis. Cell Death Differ.","DOI":"10.1038\/s41418-025-01547-y"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jid.2023.09.275","article-title":"Inhibition of Mitochondrial Translation Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation by Targeting V\u03b34+ \u03b3\u03b4 T Cells","volume":"144","author":"Braband","year":"2024","journal-title":"J. Investig. Dermatol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1172\/JCI129269","article-title":"GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis","volume":"130","author":"Xia","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.4049\/jimmunol.1901215","article-title":"Treating Autoimmune Diseases by Targeting IL-23 with Gene-Silencing Pyrrole-Imidazole Polyamide","volume":"204","author":"He","year":"2020","journal-title":"J. Immunol."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Hossen, M.M., Ma, Y., Yin, Z., Xia, Y., Du, J., Huang, J.Y., Huang, J.J., Zou, L., Ye, Z., and Huang, Z. (2023). Current understanding of CTLA-4: From mechanism to autoimmune diseases. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1198365"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1074\/jbc.M110.182394","article-title":"Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering","volume":"286","author":"Yu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"106221","DOI":"10.1016\/j.intimp.2020.106221","article-title":"CTLA-4: From mechanism to autoimmune therapy","volume":"80","author":"Hosseini","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/art.40466","article-title":"Subcutaneous Abatacept in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study","volume":"70","author":"Brunner","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Lee, W.S., Nam, K.H., Kim, J.H., Kim, W.J., Kim, J.E., Shin, E.C., Kim, G.R., and Choi, J.M. (2023). Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1233514"},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Guo, W., Xu, F., Zhuang, Z., Liu, Z., Xie, J., and Bai, L. (2021). Ebosin Ameliorates Psoriasis-Like Inflammation of Mice via miR-155 Targeting tnfaip3 on IL-17 Pathway. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.662362"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/jid.2011.161","article-title":"Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model","volume":"131","author":"Stenderup","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13543776.2017.1262350","article-title":"ROR\u03b3t inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: Patent evaluation of WO2016061160 and US20160122345","volume":"27","author":"Gege","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/bph.14550","article-title":"The role of the histamine H(4) receptor in atopic dermatitis and psoriasis","volume":"177","author":"Rossbach","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Zhu, J., Yang, T., Tang, M., Yang, Z., Pei, H., Ye, H., Tang, Y., Cheng, Z., Lin, P., and Chen, L. (2021). Studies on the anti-psoriasis effects and its mechanism of a dual JAK2\/FLT3 inhibitor flonoltinib maleate. Biomed. Pharmacother., 137.","DOI":"10.1016\/j.biopha.2021.111373"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2022.07.002","article-title":"Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial","volume":"88","author":"Armstrong","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_254","first-page":"770","article-title":"Distribution and evolution patterns of TCM syndromes in psoriasis","volume":"47","author":"Deng","year":"2006","journal-title":"J. Tradit. Chin. Med."},{"key":"ref_255","first-page":"266","article-title":"Discussion on etiology and pathogenesis of psoriasis vulgaris","volume":"44","author":"Liu","year":"2021","journal-title":"J. Beijing Univ. Tradit. Chin. Med."},{"key":"ref_256","first-page":"1569","article-title":"Study on the effect of Xijiao Dihuang Decoction on intestinal Th17\/Treg imbalance in psoriasis mice based on the gut-immune-skin axis","volume":"35","author":"Huang","year":"2023","journal-title":"Clin. J. Chin. Med."},{"key":"ref_257","first-page":"885","article-title":"Therapeutic effect of Compound Indigo Naturalis Capsule on psoriasis vulgaris and its influence on serum IL-2 and IL-8 levels","volume":"27","author":"Chen","year":"2004","journal-title":"J. Chin. Med. Mater."},{"key":"ref_258","first-page":"146","article-title":"Effect of Compound Qingdai Capsule on c-myc expression in epidermal keratinocytes of psoriasis patients","volume":"16","author":"Feng","year":"1996","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"ref_259","first-page":"1342","article-title":"Expression of p38MAPK\/Th17 signaling pathway-related cytokines in psoriasis vulgaris patients and the regulatory effect of Modified Gentian Liver-Draining Decoction","volume":"31","author":"Lei","year":"2020","journal-title":"Lishizhen Med. Mater. Medica Res."},{"key":"ref_260","first-page":"45","article-title":"Clinical observation on Compound Indigo Naturalis Ointment for treating psoriasis vulgaris","volume":"27","author":"Chen","year":"2010","journal-title":"J. Gansu Coll. Tradit. Chin. Med."},{"key":"ref_261","first-page":"127","article-title":"Meta-analysis of acupuncture efficacy for psoriasis vulgaris","volume":"36","author":"Zou","year":"2020","journal-title":"Hunan J. Tradit. Chin. Med."},{"key":"ref_262","first-page":"1769","article-title":"Effects of moving cupping therapy on peripheral blood CD4+ T lymphocyte subsets in plaque psoriasis patients with blood stasis syndrome","volume":"36","author":"Li","year":"2021","journal-title":"China J. Tradit. Chin. Med. Pharm."},{"key":"ref_263","first-page":"3023","article-title":"Efficacy of NB-UVB phototherapy combined with self-prepared Cool-Blood Anti-Itching decoction herbal bath for psoriasis vulgaris and its effects on hemorheology","volume":"26","author":"Zhou","year":"2017","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"ref_264","first-page":"541","article-title":"Effects of fire needle therapy on psoriasiform skin lesions and STAT3 pathway in imiquimod-induced mice","volume":"42","author":"Feng","year":"2022","journal-title":"Chin. Acupunct. Moxibustion"},{"key":"ref_265","first-page":"757","article-title":"Chinese herbal bath combined with NB-UVB phototherapy for stable plaque psoriasis and its impact on patients\u2019 quality of life","volume":"31","author":"Song","year":"2017","journal-title":"Chin. J. Dermatovenereology"},{"key":"ref_266","first-page":"28","article-title":"Clinical observation of NB-UVB combined with Chinese herbal fumigation for psoriasis vulgaris","volume":"18","author":"Guang","year":"2020","journal-title":"Med. Diet Health"},{"key":"ref_267","first-page":"222","article-title":"Clinical study of Shugan Jieyu Capsule in treating psoriasis vulgaris","volume":"33","author":"Chen","year":"2017","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"ref_268","first-page":"715","article-title":"Nursing observation on the interventional effects of Five-Element Jue-tone music therapy for psoriasis patients with Qi-stagnation constitution","volume":"38","author":"Dai","year":"2018","journal-title":"J. Hunan Univ. Chin. Med."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/bjd\/ljae080","article-title":"Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: An interdisciplinary perspective","volume":"191","author":"Ramessur","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.033217","article-title":"Psoriasis: Epidemiology, clinical features, and quality of life","volume":"64","author":"Langley","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"Chen, L., Su, M., Jin, Q., Wang, C.G., Assani, I., Wang, M.X., Zhao, S.F., Lv, S.M., Wang, J.W., and Sun, B. (2022). Discovery of N-(2-benzyl-4-oxochroman-7-yl)-2-(5-(ethylsulfonyl) pyridin-2-yl) acetamide (b12) as a potent, selective, and orally available novel retinoic acid receptor-related orphan receptor \u03b3t inverse agonist. Bioorganic Chem., 119.","DOI":"10.1016\/j.bioorg.2021.105483"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1615977","article-title":"Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors","volume":"377","author":"Gladman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/acr2.11740","article-title":"SOX-5 Transcription Factor: A Novel Psoriatic Autoantigen Preferentially Found in Women","volume":"6","author":"Orbai","year":"2024","journal-title":"ACR Open Rheumatol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2024.09.031","article-title":"Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial","volume":"92","author":"Yan","year":"2025","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40257-018-0396-z","article-title":"Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies","volume":"20","author":"Armstrong","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2006.05.027","article-title":"Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study","volume":"55","author":"Gordon","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ced.14412","article-title":"A phase I, randomized, double-blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF-06763809 in participants with mild-to-moderate plaque psoriasis","volume":"46","author":"Berstein","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_278","first-page":"1413","article-title":"Compound Indigo Naturalis Ointment in the Treatment of 60 Cases of Plaque Psoriasis","volume":"29","author":"Chen","year":"2014","journal-title":"Guangming J. Chin. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/18\/9233\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:47Z","timestamp":1760035607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/18\/9233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,21]]},"references-count":278,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26189233"],"URL":"https:\/\/doi.org\/10.3390\/ijms26189233","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,21]]}}}